T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal ArticleDOI
Twitter promotion predicts citation rates of cardiovascular articles: a preliminary analysis from the ESC Journals Randomized Study.
Ricardo Ladeiras-Lopes,Sarah C. Clarke,Rafael Vidal-Pérez,Michael Alexander,Thomas F. Lüscher +4 more
TL;DR: A social media strategy of Twitter promotion for cardiovascular medicine papers seems to be associated with increased online visibility and higher number of citations.
Journal ArticleDOI
Differential Effects of Captopril and Nitrates on Muscle Sympathetic Nerve Activity in Volunteers
TL;DR: It is demonstrated that vasodilators differentially interact with the SNS, which could be of importance in therapeutic strategies for the treatment of patients with cardiovascular diseases.
Journal ArticleDOI
Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome.
Matthias Naegele,Andreas J. Flammer,Frank Enseleit,Susanne Roas,Michelle Frank,Astrid Hirt,Priska Kaiser,Silviya Cantatore,Christian Templin,Georg M. Fröhlich,Michel Romanens,Thomas F. Lüscher,Frank Ruschitzka,Georg Noll,Isabella Sudano +14 more
TL;DR: The findings underscore the importance of endothelial dysfunction in patients with TTS which may be involved in the pathophysiology of this syndrome.
Journal ArticleDOI
Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads.
TL;DR: This study demonstrates that the extent of fibrotic encapsulation may not be related to the duration since lead implantation, and noted no ideal encapsulation-free site for sensors on the ventricular portion of long-term pacing leads.
Journal ArticleDOI
Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.
Daniel Sürder,Robert Manka,Robert Manka,Tiziano Moccetti,Viviana Lo Cicero,Maximilian Y. Emmert,Catherine Klersy,Sabrina Soncin,Lucia Turchetto,Marina Radrizzani,Michel Zuber,Stephan Windecker,Aris Moschovitis,Ines Bühler,Sebastian Kozerke,Paul Erne,Thomas F. Lüscher,Roberto Corti +17 more
TL;DR: In this article, autologous bone marrow-derived mononuclear cells (BM-MNC) were used to improve the left ventricle (LV) after acute myocardial infarction (AMI).